title: Epidermal growth factor receptor inhibition induces trichomegaly.
authors.affiliation: Department of Oncology, Ullevaal University Hospital, Oslo, Norway. svein.dueland@labmed.uio.no
authors.forename: Svein
authors.initials: S
authors.lastname: Dueland
authors.forename: Torill
authors.initials: T
authors.lastname: Sauer
authors.forename: Fridtjof
authors.initials: F
authors.lastname: Lund-Johansen
authors.forename: Bjørn
authors.initials: B
authors.lastname: Ostenstad
authors.forename: Kjell Magne
authors.initials: KM
authors.lastname: Tveit
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000068818:Cetuximab; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003937:Diagnosis, Differential; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005140:Eyelashes / Q000254:growth & development; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D009362:Neoplasm Metastasis
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D066246:ErbB Receptors; D000068818:Cetuximab; D002166:Camptothecin